Changes in the coronary arteries during early and long-term follow-up of Kawasaki syndrome: a single centre experience by Obersztyn, Anna et al.
ORIGINAL ARTICLE
Folia Cardiol.
2006, Vol. 13, No. 7, pp. 584–589
Copyright © 2006 Via Medica
ISSN 1507–4145
584 www.foliacardiologica.eu
Address for correspondence: Dr med. Anna Obersztyn
Clinic of Congenital Heart Disease and Paediatric Cardiology
Silesian Centre of Paediatrics in Zabrze
Szpitalna 2, 41–800 Zabrze, Poland
Tel./fax: +48 32 271 34 01; e-mail: aober@poczta.onet.pl
Received: 20.02.2006 Accepted: 6.10.2006
Changes in the coronary arteries during early and
long-term follow-up of Kawasaki syndrome:
a single centre experience
Anna Obersztyn1, Anna Baranowska1, Jarosław Rycaj1, Ireneusz Haponiuk2,
Beata Banaszak3, Katarzyna Kocyba-Matyja1 and Małgorzata Szkutnik1
1Clinic of Congenital Heart Disease and Paediatric Cardiology
Silesian Centre for Heart Disease in Zabrze, Poland
2Clinic of Cardiac Surgery and Transplantation, Silesian Medical University
Silesian Centre for Heart Disease in Zabrze, Poland
3Silesian Centre of Paediatrics in Zabrze, Poland
Abstract
Background: Kawasaki syndrome is a disease of unknown etiology manifested by fever and
the so-called mucocutaneous lymph node syndrome. In some cases aneurysms of the coronary
arteries may develop, which may result in myocardial infarction.
Methods: Four children treated for Kawasaki disease were followed up. Echocardiography
was performed in the early period of the disease and during the follow-up.
Results: Changes in the coronary arteries were diagnosed in 3 patients in early period of the
disease with one coronary aneurysm persisting in 1 patient over the entire follow-up.
Conclusions: Transthoracic echocardiography is usually sufficient to diagnose and monitor
coronary artery changes in the course of Kawasaki disease. Despite late initiation of treatment
in Kawasaki disease regression of changes in the coronaries is possible. (Folia Cardiol. 2006;
13: 584–589)
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Introduction
The anatomical basis for Kawasaki disease is
acute systemic small-vessel vasculitis, which may
also lead to changes in the coronary vessels result-
ing in ischaemic heart disease. The etiology of the
syndrome is unknown. The increased incidence of
the disease in the winter months and its cyclic re-
currences, approximately every 3 years, may be
suggestive of viral aetiology [1]. Genetic back-
ground cannot be ruled out either. The disease may
be recurrent with a subsequent relapse occurring
several years later [2].
Although its prevalence peaks usually between
the age of 2 months and 5 years, Kawasaki disease
may occasionally develop in patients up to 34 years
of age. The typical clinical manifestations of Kawa-
saki disease include: fever, polymorphous rash,
mucositis, conjunctivitis, lymphadenitis and the
characteristic skin lesions involving distal parts of
the extremities (in the order of appearance): pallor,
erythema and oedema, followed by desquamation
of the fingers and toes [3]. The average duration of
fever is 11 days, although it may persist for up to
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3-4 weeks. The rash usually appears within 5 days of
the onset of disease and the conjunctivitis develops
soon after the onset of fever. Desquamation of the fin-
gertips and toes develops later, within 2–3 weeks.
Aneurysms may develop in peripheral vessels.
Cardiac complications may include pericarditis,
myocarditis and endocarditis, involvement of the
conduction system and coronary arteritis. The in-
flammation involving the coronary arteries may lead
to their narrowing or the formation of aneurysms,
which may result in myocardial ischaemia and my-
ocardial infarction, which is the main cause of death.
Coronary aneurysms develop within 10 days of the
onset of the disease and beeing observed in 90% of
cases with poor outcome [4].
The diagnosis of Kawasaki disease is estab-
lished clinically with a minimum of 4 typical mani-
festations being required for the diagnosis [3, 5].
The differential diagnosis should include diseases
with similar clinical course, such as measles, scar-
let fever, roseola, allergic drug reactions and juve-
nile rheumatoid arthritis [6].
Laboratory tests are not characteristic (elevated
WBC counts with a left shift, increased ESR, possi-
bly mild anaemia) except for platelet count elevation
above 500 000/ml which appears in the second or third
week. If involvement of the coronary vessels, myo-
cardium or the pericardium is suspected, ECG and
echocardiographic monitoring is warranted. In justi-
fied cases coronary arteriography is required.
Pharmacotherapy in the initial phase of the dis-
ease involves the use of immunoglobulin at a sin-
gle dose of 1–2 g/kg (administered within the first
10 days of the onset of symptoms), followed by sali-
cylates at an anti-inflammatory dose of 80–100 mg/kg
until 14 days of onset or until 2–3 days after the
resolution of fever. If no improvement is seen, cor-
ticosteroids are recommended. The currently sug-
gested treatment regimen involves intravenous
pulses of methylprednisolone at a dose of 30 mg/kg
once daily for 1–3 days. Such treatment may limit
the formation of coronary artery aneurysms [5]. In the
later phase of the disease, i.e. after 14 days of onset,
salicylates at the anti-aggregation dose (3–5 mg/kg)
are intended to prevent thrombotic complications
in the coronary arteries. If large (more than 6 mm
in diameter) or multiple aneurysms are detected,
treatment with acenocoumarol (while maintaining
INR within the range of 2.0–2.5) or standard-dose
heparin may be indicated [5]. In spite of the treat-
ment, the consequences of the inflammation in the
coronary vessels may be very serious.
The aim of this case series report is to present
the course and outcome of late follow-up of four
patients managed for Kawasaki disease in whom the
diagnosis was established on the basis of clinical and
laboratory findings and the complications were di-
agnosed by echocardiography and further confirmed
by coronary arteriography.
Methods
Four patients (2 boys and 2 girls) with a diag-
nosis of Kawasaki syndrome were followed up. The
age at diagnosis ranged from 9 months to 3 years
and the duration of follow-up was 1 to 10 years. The
patients underwent echocardiography in the early
period of the disease and in the late follow-up peri-
od (Sonos 2000, Sonos 4500 and Sonos 750 with
3.5/2.5 MHz and 7.5/5.5 MHz heads). The initial
segments of the coronary vessels were imaged in
the parasternal short axis view. In addition, three
children underwent coronary arteriography (2 in the




A 9-month-old boy (PT) developed an episode
of high fever of 8 days’ duration refractory to anti-
inflammatory agents 6 weeks prior to presentation
to our centre. The fever was accompanied by con-
junctivitis, cervical lymphadenopathy and upper
respiratory tract infection. The child was hospital-
ised at the Paediatric Intensive Care Unit, where
on several occasions he developed episodes of sud-
den deterioration of his general condition starting
with anxiety attacks. During the episodes supraven-
tricular tachycardias accompanied by impaired con-
sciousness were observed. The child was then
transferred to our centre.
The ECG performed at our clinic revealed
changes suggestive of an ischaemic episode in the
past involving the anterior wall of the myocardium.
The echocardiography performed 6 weeks of
the onset of the disease revealed a widening of the
left coronary artery (LCA), normal myocardial con-
tractility an no other abnormal findings (Fig. 1).
Coronary arteriography was performed, which con-
firmed the presence of an LCA aneurysm measur-
ing 4 mm × 15 mm. The arteriography also revealed
narrowing of the iliac arteries and their branches
and two hourglass-like narrowings of the aorta
— one below the coeliac trunk and the other below
the renal arterial ostia.
During the in-hospital observation, when the
child was monitored by ECG, he developed two
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episodes of flaccidity followed by generalised con-
vulsions and impaired consciousness, which re-
solved several minutes later. During the episodes
ECG revealed supraventricular tachycardia of up to
180 bpm. The episodes of tachycardia were man-
aged with an infusion of Cordarone at a dose of
5 mg/kg. Taking into account the possibility of vas-
cular changes in the central nervous system, an
MRI scan of the central nervous system was per-
formed. No such changes were, however, revealed.
Due to the considerable time interval between
the first manifestations of disease and the diagno-
sis, immunoglobulin treatment was not initiated.
Because of the presence of a coronary artery aneu-
rysm and the elevated D-dimer levels heparin at
a dose of 50 IU/kg was given for 4 days, followed by
acenocoumarol (INR 2.5–3.5). In addition, sali-
cylates at the anti-aggregation dose (5 mg/kg) were
started. Arrythmia was managed with beta-block-
ers: propranolol at a dose of 2 mg/kg, followed by
metoprolol at a dose of 1 mg/kg subsequently re-
duced to 0.5 mg/kg and Cordarone (at a starting dose
of 10 mg/kg, followed by 5 mg/kg). After 28 days of
hospitalisation the boy was discharged home in
a good general condition with a recommendation to
continue the anti-aggregation treatment with sali-
cylates at a dose of 5 mg/kg, the anticoagulant treat-
ment with acenocoumarol (with INR monitored) and
the anti-arrhythmic treatment with Cordarone at
a dose of 2.5 mg/kg and metoprolol at a dose of
0.5 mg/kg. Further follow-up did not reveal the pre-
vious symptoms. Six months after the onset of the
disease the boy returned to our centre for follow-up
examinations. Standard ECG did not reveal any
signs of myocardial ischaemia or arrhythmia. The
24-hour ambulatory ECG recordings appeared nor-
mal. Echocardiography did not reveal the previously
reported coronary artery aneurysm, which was sub-
sequently confirmed by coronary arteriography.
Given no abnormal findings, especially given the
regression of changes in the coronary vessels, the
salicylates, anticoagulants and the beta-blocker
were discontinued. Six months later (i.e. a year af-
ter the start of treatment) the child returned for
another follow-up visit at the outpatient clinic. ECG
and echocardiography showed no abnormalities.
The next visit took place 5 years after the diagno-
sis. The physical examination revealed no abnor-
mal findings in the cardiovascular system and both
ECG and echocardiography were unremarkable.
Case 2
A 20-month-old girl (JK) developed a protract-
ed fever, polymorphous rash and mucositis, for
which she was admitted to her local hospital. No
symptoms suggestive of myocardial ischaemia were
observed during this period. Two months after the
onset of symptoms the child was referred to our
centre with suspected Kawasaki syndrome.
Echocardiography revealed a LCA aneurysm
(7 mm in diameter and 10 mm in length). These le-
sions were confirmed by coronary arteriography
(the length of the aneurysm was 16.5 mm and its
width was 8 mm to 10 mm). No clinical, electrocar-
diographic or echocardiographic signs of myocardial
ischaemia were noted. Salicylates at an anti-aggre-
gation dose (5 mg/kg) were added to the treatment
regimen. After two weeks of observation the child
was discharged home with a recommendation to con-
tinue the anti-aggregation treatment. The follow-up
coronary arteriography performed 12 months after
the acute phase revealed a reduction of the diame-
ter and length of the aneurysm to approximately
5 mm and 11 mm, respectively.
The aneurysmal LCA widening of up to 4–6 mm,
confirmed by repeated echocardiographies performed
at the outpatient clinic (Fig. 2), and by coronary arte-
riography performed 9 years after the diagnosis
(Fig. 3, 4), persisted over the 10-year-long follow-up.
The girl denied any symptoms and there were no new
changes on ECG or echocardiography. The size and
systolic function of the left ventricle were normal.
Since the diagnosis of Kawasaki syndrome the
child has been on long-term treatment with acetyl-
salicylic acid at an anti-aggregation dose (currently
5 mg/kg).
Figure 1. A 9-month-old patient with the initial diagno-
sis of Kawasaki syndrome, 6 weeks after the primary
diagnosis. Echocardiography, parasternal view, short
axis. The aortic valve and dilated initial segments of left
coronary artery and right coronary artery.
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Case 3
A 16-month-old girl (MC) presented with
symptoms of pharyngitis accompanied by lymphad-
enopathy, a roseola-like rash, desquamation of the
fingertips and toes, and protracted fever. No clini-
cal signs of cardiac involvement were observed.
After the initial outpatient treatment the child was
hospitalised at a paediatric ward. Five weeks after
the onset of disease the child was transferred to our
centre with suspected Kawasaki disease. The
echocardiography performed on admission revealed
areas of cylindrical widening in the initial segments
of the left and right coronary arteries (RCA) of up
to 4 mm, without aneurysmal changes. No other
abnormalities were found on echocardiography.
ECG was unremarkable. The subsequent echocar-
diographies revealed a further widening of the cor-
onary arteries of approximately 1 mm in RCA and
LCA (a total diameter of 5 mm). The outlines of the
vessels remained smooth.
Although 5 weeks had elapsed since the onset
of the disease, a therapeutic infusion of immu-
noglobulin at a dose of 2 g/kg was administered. Due
to the presence of elevated D-dimer levels heparin
at a dose of 50 IU/kg was given for 5 days, followed
by anticoagulants (INR 2.5–3.5). Salicylates at the
anti-aggregation dose (5 mg/kg) were also started.
Because the widening of the coronary arteries pro-
gressed, the patient was started on corticosteroids
(prednisolone at a dose of 1 mg/kg for 7 days). Dur-
ing the hospitalisation the patient’s respiratory in-
fection exacerbated and the coronary arteriography
had to be rescheduled for a later date. The girl was
transferred back for further treatment. One month
later she was readmitted to our centre and the
haemodynamic study revealed coronary arteries of
normal morphology and without postinflammatory
lesions. The LCA and RCA diameters were 3.2 mm
Figure 4. A 20-month-old patient with the initial diagno-
sis of Kawasaki syndrome, 10 years after the primary
diagnosis. Coronary angiography, AP view. The arrow
indicates the aneurysm of the left main coronary artery
(10 mm × 4 mm).
Figure 3. A 20-month-old patient with the initial diagno-
sis of Kawasaki syndrome, 10 years after the primary
diagnosis. Coronary angiography, AP view. The arrow
indicates the aneurysm of the left main coronary artery.
Figure 2. A 20-month-old patient with the initial diagno-
sis of Kawasaki syndrome, 10 years after the primary
diagnosis. Echocardiography, parasternal view, short
axis. The aortic valve and the initial segments of left
coronary artery and right coronary artery. The arrow
indicates the left main coronary artery aneurysm.
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and 3.4 mm, respectively. Similar dimensions and
smooth outlines of the coronary vessels were also
revealed by echocardiography. The anti-aggregation
treatment with salicylates at a dose of 5 mg/kg was
continued. Given an almost complete regression of
the picture of the coronary artery changes, antico-
agulants were discontinued after 6 weeks of use. On
the 10th day of observation the girl was discharged
from hospital. Over a year of outpatient follow-up
since the diagnosis a normal echocardiographic pic-
ture of the coronary vessels was confirmed and the
anti-aggregation treatment was discontinued.
During the follow-up outpatient visits over
3 years of observation, the child’s general condition
was good, no disturbing clinical manifestations were
observed, the ECG tracings were normal and the
echocardiographic picture did not change.
Case 4
A 3-year-old boy (KM) developed mucocutane-
ous lymph node syndrome and low-grade fever. He
was initially managed as an outpatient with a sus-
pected flu-like infection. Due to the lack of improve-
ment he was admitted to the paediatric ward of his
local hospital. Given the clinical picture suggestive
of Kawasaki disease and considerably elevated in-
flammation markers, two weeks after the onset of
symptoms the boy was given a single infusion of
immunoglobulin at a dose of 2 g/kg and was started
on acetylsalicylic acid at an anti-inflammatory dose
(80 mg/kg). No signs of myocardial ischaemia were
observed. The boy was transferred to our centre
four weeks after the onset of symptoms.
The echocardiography performed on admission
revealed coronary vessels of normal morphology
and the ECG tracing was unremarkable. After
10 days of observation, the child was discharged
home in good general condition. Treatment with sal-
icylates at a dose of 50 mg/kg was continued for
1 month, when the dose was reduced to an anti-ag-
gregation dose of 5 mg/kg. No clinical, electrocar-
diographic or echocardiographic abnormalities were
observed during the outpatient follow-up examina-
tion performed 3 months after the diagnosis or over
the subsequent 1.5 years of observation. Given the
normal picture of the coronary vessels, the anti-
aggregation treatment was discontinued at
3 months after the diagnosis.
Discussion
Coronary artery aneurysms in the course of
Kawasaki disease are found in 15–25% of children
who have not received appropriate treatment [5].
In the literature, the need for early (i.e. within the
first 10 days of onset) administration of immu-
noglobulin and anti-inflammatory treatment to pre-
vent the involvement of coronary vessels is empha-
sised [5]. In some cases this is obviously difficult
due to delayed diagnosis (unclear clinical picture).
Kawasaki disease may be misdiagnosed as another
exanthaematous disease. Although not all patients
with Kawasaki disease may present with all the four
characteristic symptoms and in some cases the dis-
ease mayby oligo- or asymptomatic, the coronary
vessels may still become affected (the so-called
atypical Kawasaki syndrome) [5]. Even patients
who have been treated with immunoglobulin at the
early phase of the disease may still develop struc-
tural and functional intimal changes in the coronary
vessels. Until they develop into a serious coronary
artery narrowing, such changes are clinically silent
and echocardiographically undetectable at the ear-
ly stage of the disease [7]. In some patients, coro-
nary artery aneurysms spontaneously regress [5].
This regression, however, occurs at the expense of
abnormal remodelling and dysfunction of the coro-
nary vessel endothelium [5, 8]. According to the
current recommendations, anti-aggregation treat-
ment with salicylates (5–10 mg/kg) is continued for
6–8 weeks in patients who, despite other manifes-
tations of the disease, have not developed coronary
artery changes or in patients who have developed
a transient widening of a coronary artery (i.e. a wid-
ening which regressed within 1.5–2 months). Pa-
tients with a single coronary vessel aneurysm with
a diameter of 3–6 mm require anti-aggregation
treatment for as long as the aneurysm is present.
Patients with giant aneurysms (exceeding 10 mm
in diameter) or with complex aneurysms usually
require permanent anti-aggregation treatment due
to the low probability of regression of such large
aneurysms. Anticoagulants are also indicated in
these patients.
In none of the cases of Kawasaki syndrome
presented above was it possible to establish the
diagnosis within the first ten days of onset of the
disease, which caused delay of initiation of appro-
priate treatment. In two cases, however, a decision
to administer immunoglobulin infusion was made.
While one of the patients showed no changes in the
coronary arteries, the coronary changes observed
in the other one regressed within a month. In one
case, the lesions regressed spontaneously within
6 months of observation despite the lack of treat-
ment with immunoglobulin and anti-inflammatory
agents. Only in one case the coronary artery aneurysm
has persisted over the 10 years of follow-up. This
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patient was diagnosed relatively late, which was why
only prophylactic antithrombotic treatment was ini-
tiated. Only one patient developed clinical manifes-
tations of myocardial ischaemia, which subsequent-
ly resolved. No cases of myocardial infarction were
observed (this includes the child with the coronary
aneurysm persisting over the 10 years of follow-up).
In the diagnosis of coronary artery involve-
ment, apart from cardiac ultrasound, coronary ang-
iography is useful. It is particularly helpful in visu-
alisation of the distal coronary segments at early
stages of the disease as well as at later stages in
patients in which cardiac ultrasound revealed re-
gression of proximal coronary aneurysms. In the
cases described above, the diagnosis was mainly
based on echocardiography and the results of coro-
nary arteriography were consistent with the
echocardiography findings. Other coronary vessel
imaging techniques are also available, such as MRI
or ultrafast CT [5].
Due to its non-invasiveness, wide availability
and the possibility of being frequently repeated,
echocardiography still remains the mainstay of dia-
gnosis of cardiac complications in Kawasaki disease
[5, 9, 10].
Conclusions
1. Transthoracic echocardiography is usually suf-
ficient to diagnose and monitor coronary artery
changes in the course of Kawasaki disease.
2. Despite late initiation of treatment in Kawasa-
ki disease regression of changes in the coro-
nary vessels is possible.
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